FDA Regulation of Combination Products - PowerPoint PPT Presentation

About This Presentation
Title:

FDA Regulation of Combination Products

Description:

A combination product is a product composed of any combination of a drug and a device; a biological product and a device; a drug and a biological product; or a drug, device, and a biological product. – PowerPoint PPT presentation

Number of Views:94
Updated: 28 May 2015
Slides: 6
Provided by: Compliance4all

less

Transcript and Presenter's Notes

Title: FDA Regulation of Combination Products


1
FDA Regulation of Combination Products
2
Speaker Profile
  • Thomas E. Colonna earned a bachelor of science in
    microbiology from the University of Sciences in
    Philadelphia (formerly the Philadelphia College
    of Pharmacy and Science), a Ph.D. in molecular
    biology from the Johns Hopkins University, and a
    law degree from the Georgetown University Law
    Center. In addition, Dr. Colonna holds academic
    appointments at Johns Hopkins University and the
    University of Sciences in Philadelphia. Dr.
    Colonna provides consulting services in the
    scientific and regulatory aspects of a wide range
    of medical devices and biologics with particular
    expertise in the areas of in vitro diagnostics
    (ELISA-based, PCR-based, SNPs, microarrays, and
    pharmacogenomics), medical device software
    (including bioinformatics), and
    biotechnology-based products. Dr. Colonnas
    consulting clients range from Fortune 500
    companies to small start-up companies located
    throughout the US, as well as, Canada, India, and
    Russia. Widely published in numerous fields, Dr.
    Colonna brings a unique multidisciplinary
    approach to problem solving.

3
Overview
  • Overview A combination product is a product
    composed of any combination of a drug and a
    device a biological product and a device a drug
    and a biological product or a drug, device, and
    a biological product. Combination products are
    therapeutic and diagnostic products that combine
    drugs, devices, and/or biological products. FDA
    expects to receive large numbers of combination
    products for review as technological advances
    continue to merge product types and blur the
    historical lines of separation between FDAs
    medical product centers, which are made up of the
    Center for Biologics Evaluation and Research
    (CBER), the Center for Drug Evaluation and
    Research (CDER), and the Center for Devices and
    Radiological Health (CDRH). 

4
Areas Covered in the Session
  • Definition of combination product
  • FDA Regulatory Pathways
  • Primary Mode of Action
  • User Fees

5
Connect with us
  • www.compliance4all.com
  • https//www.facebook.com/compliance4all
  • https//twitter.com/compliance4all
  • https//www.pinterest.com/compliance4all
Write a Comment
User Comments (0)
About PowerShow.com